Accuracy Coverage Pricing Help Centre Contact
Perrigo Company plc

Perrigo Company plc (PRGO) Dividends

Dividend Summary:

The next Perrigo Company plc dividend is expected to go ex in 2 months and to be paid in 2 months.
The previous Perrigo Company plc dividend was 22.5c and it went ex 1 month ago and it was paid 17 days ago.
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 5.1.
Country:
United States
Exchange:
New York Stock Exchange
Sector:
Pharmaceuticals & Biotechnology
  Previous Dividend Next Dividend
Status: Paid Forecast
Type: Quarterly Quarterly
Per Share: 22.5c Sign Up Required
Ex-div Date: Thu 28 May 2020 Thu 27 Aug 2020
Pay Date: Tue 16 Jun 2020 Tue 15 Sep 2020
Your Holding: 100 shares 100 shares
Your Payment: $22.50 Sign Up Required

Dividend Payment Calculator

Enter the number of shares you hold:

shares
Calculate Payment

Free dividend email notifications

Declared and Forecast Perrigo Company plc Dividends

Ex-Div Date Pay Date Type Amount Currency Status
01 Mar 2012 unknown Quarterly 8c USD Paid
31 May 2012 unknown Quarterly 8c USD Paid
30 Aug 2012 unknown Quarterly 8c USD Paid
28 Nov 2012 unknown Quarterly 9c USD Paid
28 Feb 2013 unknown Quarterly 9c USD Paid
30 May 2013 unknown Quarterly 9c USD Paid
28 Aug 2013 17 Sep 2013 Quarterly 9c USD Paid
26 Nov 2013 17 Dec 2013 Quarterly 9c USD Paid
19 Dec 2013 unknown Special 1c USD Paid
26 Feb 2014 18 Mar 2014 Quarterly 10.5c USD Paid
28 May 2014 17 Jun 2014 Quarterly 10.5c USD Paid
27 Aug 2014 16 Sep 2014 Quarterly 10.5c USD Paid
25 Nov 2014 16 Dec 2014 Quarterly 10.5c USD Paid
25 Feb 2015 17 Mar 2015 Quarterly 12.5c USD Paid
27 May 2015 16 Jun 2015 Quarterly 12.5c USD Paid
26 Aug 2015 15 Sep 2015 Quarterly 12.5c USD Paid
24 Nov 2015 15 Dec 2015 Quarterly 12.5c USD Paid
24 Feb 2016 15 Mar 2016 Quarterly 14.5c USD Paid
25 May 2016 14 Jun 2016 Quarterly 14.5c USD Paid
24 Aug 2016 13 Sep 2016 Quarterly 14.5c USD Paid
22 Nov 2016 13 Dec 2016 Quarterly 14.5c USD Paid
01 Mar 2017 21 Mar 2017 Quarterly 16c USD Paid
24 May 2017 13 Jun 2017 Quarterly 16c USD Paid
23 Aug 2017 12 Sep 2017 Quarterly 16c USD Paid
30 Nov 2017 19 Dec 2017 Quarterly 16c USD Paid
01 Mar 2018 20 Mar 2018 Quarterly 19c USD Paid
31 May 2018 19 Jun 2018 Quarterly 19c USD Paid
30 Aug 2018 18 Sep 2018 Quarterly 19c USD Paid
29 Nov 2018 18 Dec 2018 Quarterly 19c USD Paid
28 Feb 2019 19 Mar 2019 Quarterly 19c USD Paid
30 May 2019 18 Jun 2019 Quarterly 21c USD Paid
29 Aug 2019 17 Sep 2019 Quarterly 21c USD Paid
27 Nov 2019 17 Dec 2019 Quarterly 21c USD Paid
27 Feb 2020 17 Mar 2020 Quarterly 22.5c USD Paid
28 May 2020 16 Jun 2020 Quarterly 22.5c USD Paid
27 Aug 2020 15 Sep 2020 Quarterly Sign Up Required USD Forecast
25 Nov 2020 15 Dec 2020 Quarterly Sign Up Required USD Forecast
25 Feb 2021 16 Mar 2021 Quarterly Sign Up Required USD Forecast
27 May 2021 15 Jun 2021 Quarterly Sign Up Required USD Forecast
26 Aug 2021 14 Sep 2021 Quarterly Sign Up Required USD Forecast
24 Nov 2021 14 Dec 2021 Quarterly Sign Up Required USD Forecast
24 Feb 2022 15 Mar 2022 Quarterly Sign Up Required USD Forecast
26 May 2022 14 Jun 2022 Quarterly Sign Up Required USD Forecast
25 Aug 2022 13 Sep 2022 Quarterly Sign Up Required USD Forecast
23 Nov 2022 13 Dec 2022 Quarterly Sign Up Required USD Forecast
02 Mar 2023 21 Mar 2023 Quarterly Sign Up Required USD Forecast
25 May 2023 13 Jun 2023 Quarterly Sign Up Required USD Forecast
24 Aug 2023 12 Sep 2023 Quarterly Sign Up Required USD Forecast
30 Nov 2023 19 Dec 2023 Quarterly Sign Up Required USD Forecast
29 Feb 2024 19 Mar 2024 Quarterly Sign Up Required USD Forecast
30 May 2024 18 Jun 2024 Quarterly Sign Up Required USD Forecast
29 Aug 2024 16 Sep 2024 Quarterly Sign Up Required USD Forecast

How accurate are our Perrigo Company plc forecasts?

Prediction Date Dividend Date Forecast Amount Actual Amount Accuracy
04 May 2020 28 May 2020 24c 22.5c 96% πŸ˜ƒ
18 Feb 2020 28 May 2020 24c 22.5c 96% πŸ˜ƒ
08 Nov 2019 28 May 2020 23c 22.5c 99% πŸ˜ƒ
08 Nov 2019 27 Feb 2020 21c 22.5c 96% πŸ˜ƒ
07 Aug 2019 28 May 2020 24c 22.5c 96% πŸ˜ƒ
07 Aug 2019 27 Feb 2020 21c 22.5c 96% πŸ˜ƒ
07 Aug 2019 27 Nov 2019 21c 21c 100% πŸ˜„
Average Perrigo Company plc Forecast Accuracy 97% πŸ˜ƒ

Access our Perrigo Company plc dividend forecasts and the suite of investor tools free for 30 days.

Try DividendMax free for 30 days

About Perrigo Company plc

Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, incorporated on June 28, 2013, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences. The Company manufactures OTC healthcare products and supplies infant formulas for the store brand market. It is also a provider of generic extended topical prescription products. It provides healthcare products across a range of product categories and geographies, primarily in North America, Europe and Australia, as well as in other markets, including Israel and China.

Consumer Healthcare

The Company's CHC segment is focused on the sale of OTC store brand products, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food and diagnostic products. The Company markets in various geographies, including the United States, the United Kingdom and Mexico. Its branded products include the Good Sense, Sergeant's, Sentry, Herron, PetArmor value brands, and the ScarAway brand name.

Branded Consumer Healthcare

The Company's BCH segment develops, manufactures, markets and distributes various European OTC brands in categories, such as natural health, cough, cold and allergy, personal care and derma-therapeutics, lifestyle and pain relief. In addition, the segment manages its regulatory, sales and distribution infrastructure to in-license, and sells non-owned brands and generic pharmaceutical products.

Prescription Pharmaceuticals

The Company's Rx segment develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs for the United States and the United Kingdom markets. It offers a range of topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions and powders. The portfolio also includes select controlled substances, injectables, hormones, women's health products, oral solid dosage forms and oral liquid formulations. Its development areas include other delivery systems, such as oral liquids, metered dose inhalers, injectables and transdermal products. In addition, the Rx segment offers OTC products through the prescription channel (referred to as ORx, these products are marketed using the Perrigo name). ORx products are OTC products that are available for pharmacy fulfillment and healthcare reimbursement when prescribed by a physician. It offers various ORx products that are reimbursable through various health plans and the United States Medicaid and Medicare programs. It manufactures and distributes a range of generic prescription products under various brand names, including Differin, BenzaClin, Entocort, Evoclin, Duac, Olux, Olux-E, Clobex, Desonate, Tridesilon, D.H.E. 45, Ultravate, Bactroban, Mycostatin, Elimite, Klor-Con, Protopic, Androgel, Depo, Testosterone and Triderm/Kenalog.

Specialty Sciences

The Company's Specialty Sciences segment consists of assets focused on the treatment of multiple sclerosis, specifically in connection with the drug, Tysabri (natalizumab). Tysabri also focused on the treatment of Crohn’s diseases.

The Company competes with LNK International, Inc., PL Developments, International Vitamin Corporation, Dr. Reddy's Labs, Johnson & Johnson, Pfizer, Bayer AG, Nestle S.A., Abbott Nutrition, NBTY, Mead Johnson Nutrition Co., Reckitt Benckiser, Boehringer Ingelheim, Novartis, Allergan plc, Apotex Corp., Glenmark Generics Inc., Impax Laboratories, Inc., Mylan N.V., Prasco, LLC, Sandoz, Sun Pharmaceuticals, Taro Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Triax Pharmaceuticals, LLC and Zydus Pharmaceuticals, Inc.

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0c
2007 0.0c 0%
2008 0.0c 0%
2009 0.0c 0%
2010 0.0c 0%
2011 0.0c 0%
2012 24.0c 100%
2013 36.0c 50.0%
2014 40.5c 12.5%
2015 48.0c 18.5%
2016 56.0c 16.7%
2017 62.5c 11.6%
2018 73.0c 16.8%
2019 80.0c 9.6%
2020 Login required
2021 Login required
2022 Login required
2023 Login required
2024 Login required

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount
01 Mar 2012 unknown 2012 Interim Quarterly Paid 8c
31 May 2012 unknown 2012 Interim Quarterly Paid 8c
30 Aug 2012 unknown 2012 Final Quarterly Paid 8c
28 Nov 2012 unknown 2013 Interim Quarterly Paid 9c
28 Feb 2013 unknown 2013 Interim Quarterly Paid 9c
30 May 2013 unknown 2013 Interim Quarterly Paid 9c
28 Aug 2013 17 Sep 2013 2013 Final Quarterly Paid 9c
26 Nov 2013 17 Dec 2013 2014 Interim Quarterly Paid 9c
19 Dec 2013 unknown 2014 Special Irregularly Paid 1c
26 Feb 2014 18 Mar 2014 2014 Interim Quarterly Paid 10.5c
28 May 2014 17 Jun 2014 2014 Interim Quarterly Paid 10.5c
27 Aug 2014 16 Sep 2014 2014 Final Quarterly Paid 10.5c
25 Nov 2014 16 Dec 2014 2015 Interim Quarterly Paid 10.5c
25 Feb 2015 17 Mar 2015 2015 Interim Quarterly Paid 12.5c
27 May 2015 16 Jun 2015 2015 Interim Quarterly Paid 12.5c
26 Aug 2015 15 Sep 2015 2015 Final Quarterly Paid 12.5c
24 Nov 2015 15 Dec 2015 2016 Interim Quarterly Paid 12.5c
24 Feb 2016 15 Mar 2016 2016 Interim Quarterly Paid 14.5c
25 May 2016 14 Jun 2016 2016 Interim Quarterly Paid 14.5c
24 Aug 2016 13 Sep 2016 2016 Final Quarterly Paid 14.5c
22 Nov 2016 13 Dec 2016 2017 Interim Quarterly Paid 14.5c
01 Mar 2017 21 Mar 2017 2017 Interim Quarterly Paid 16c
24 May 2017 13 Jun 2017 2017 Interim Quarterly Paid 16c
23 Aug 2017 12 Sep 2017 2017 Final Quarterly Paid 16c
30 Nov 2017 19 Dec 2017 2018 Interim Quarterly Paid 16c
01 Mar 2018 20 Mar 2018 2018 Interim Quarterly Paid 19c
31 May 2018 19 Jun 2018 2018 Interim Quarterly Paid 19c
30 Aug 2018 18 Sep 2018 2018 Final Quarterly Paid 19c
29 Nov 2018 18 Dec 2018 2019 Interim Quarterly Paid 19c
28 Feb 2019 19 Mar 2019 2019 Interim Quarterly Paid 19c
30 May 2019 18 Jun 2019 2019 Interim Quarterly Paid 21c
29 Aug 2019 17 Sep 2019 2019 Final Quarterly Paid 21c
27 Nov 2019 17 Dec 2019 2020 Interim Quarterly Paid 21c
27 Feb 2020 17 Mar 2020 2020 Interim Quarterly Paid 22.5c
28 May 2020 16 Jun 2020 2020 Interim Quarterly Paid 22.5c
Sign Up Required Sign Up Required 2020 Final Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2021 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2021 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2021 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2021 Final Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2022 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2022 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2022 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2022 Final Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2023 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2023 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2023 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2023 Final Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2024 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2024 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2024 Interim Quarterly Forecast Sign Up Required
Sign Up Required Sign Up Required 2024 Final Quarterly Forecast Sign Up Required

Perrigo Company plc optimized dividend - 12 month history